CPLD 2005 FFA vs Respondent M49

Facts
The French Athletics Federation (Fédération Française d'athlétisme, FFA) charges respondent M49 for a violation of the Anti-Doping Rules. During an athletics event on July 6, 2005, respondent provided a sample for doping test purposes. Analysis of the sample showed the presence of a metabolite of budesonide. Budesonide is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
Respondent claims the need for medication because of a medical condition. It appears from the medical record that the respondent would be subject to longstanding medical treatment; but documents submitted by the interested to the Council do not involve any element of nature that establish the reality of this disease.

Decision
1. The sanction is a period of ineligibility of three months in which respondent can't take part in competition or manifestations organized or authorize by the FFA.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
10 October 2005
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Conseil de Prévention et de Lutte contre le Dopage (CPLD) - Council to Prevent and Counteract Doping
Fédération française d'athlétisme (FFA) - French Athletics Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Budesonide
Document type
Pdf file
Date generated
28 November 2014
Date of last modification
13 March 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin